Evidence map›Paper›PMID 27911804›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation.

Hanne Van Gorp, Pedro H V Saavedra, Nathalia M de Vasconcelos, Nina Van Opdenbosch, Lieselotte Vande Walle, Magdalena Matusiak, Giusi Prencipe, Antonella Insalaco, Filip Van Hauwermeiren, Dieter Demon and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 1 synthesis or guideline pooled it, 177 citations in OpenAlex.

  1. Pooled it
  2. Subclinical corneal endothelial alterations in Familial Mediterranean Fever patients during clinical remission.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Hyperimmunoglobulin syndromes: A review of HIGM, HIES, and HIDS.Journal of translational autoimmunity · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Hanne Van GorpInflammation Research Center, VIB, Zwijnaarde, B-9052, Belgium.
Pedro H V SaavedraInflammation Research Center, VIB, Zwijnaarde, B-9052, Belgium.
Nathalia M de VasconcelosInflammation Research Center, VIB, Zwijnaarde, B-9052, Belgium.
Nina Van OpdenboschInflammation Research Center, VIB, Zwijnaarde, B-9052, Belgium.
Lieselotte Vande WalleInflammation Research Center, VIB, Zwijnaarde, B-9052, Belgium.
Magdalena MatusiakInflammation Research Center, VIB, Zwijnaarde, B-9052, Belgium.
Giusi PrencipeRheumatology Unit, Bambino Gesù Children's Hospital, Rome, I-00146, Italy.
Antonella InsalacoRheumatology Unit, Bambino Gesù Children's Hospital, Rome, I-00146, Italy.
Filip Van HauwermeirenInflammation Research Center, VIB, Zwijnaarde, B-9052, Belgium.
Dieter DemonInflammation Research Center, VIB, Zwijnaarde, B-9052, Belgium.
Delfien J BogaertClinical Immunology Research Laboratory, Centre for Primary Immunodeficiency Ghent, Ghent University Hospital, Ghent, B-9000, Belgium.
Melissa DullaersClinical Immunology Research Laboratory, Centre for Primary Immunodeficiency Ghent, Ghent University Hospital, Ghent, B-9000, Belgium.
Elfride De BaereCenter for Medical Genetics Ghent, Ghent University, Ghent, B-9000, Belgium.
Tino HochepiedInflammation Research Center, VIB, Zwijnaarde, B-9052, Belgium.
Joke DehoorneDepartment of Pediatric Rheumatology, Ghent University Hospital, Ghent, B-9000, Belgium.
Karim Y VermaelenDepartment of Internal Medicine, Ghent University, Ghent, B-9000, Belgium.
Filomeen HaerynckClinical Immunology Research Laboratory, Centre for Primary Immunodeficiency Ghent, Ghent University Hospital, Ghent, B-9000, Belgium.
Fabrizio De BenedettiRheumatology Unit, Bambino Gesù Children's Hospital, Rome, I-00146, Italy.
Mohamed LamkanfiInflammation Research Center, VIB, Zwijnaarde, B-9052, Belgium; mohamed.lamkanfi@irc.vib-ugent.be.
Ghent University · BEGhent University Hospital · BEVIB-UGent Center for Inflammation Research · BEBambino Gesù Children's Hospital · IT

Funding

European Research Council 281600
6 · The paper itself

Abstract

Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease worldwide. It is caused by mutations in the inflammasome adaptor Pyrin, but how FMF mutations alter signaling in FMF patients is unknown. Herein, we establish Clostridium difficile and its enterotoxin A (TcdA) as Pyrin-activating agents and show that wild-type and FMF Pyrin are differentially controlled by microtubules. Diverse microtubule assembly inhibitors prevented Pyrin-mediated caspase-1 activation and secretion of IL-1β and IL-18 from mouse macrophages and human peripheral blood mononuclear cells (PBMCs). Remarkably, Pyrin inflammasome activation persisted upon microtubule disassembly in PBMCs of FMF patients but not in cells of patients afflicted with other autoinflammatory diseases. We further demonstrate that microtubules control Pyrin activation downstream of Pyrin dephosphorylation and that FMF mutations enable microtubule-independent assembly of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) micrometer-sized perinuclear structures (specks). The discovery that Pyrin mutations remove the obligatory requirement for microtubules in inflammasome activation provides a conceptual framework for understanding FMF and enables immunological screening of FMF mutations.

Indexed as

MutationAnimalsBacterial ToxinsCARD Signaling Adaptor ProteinsClostridium InfectionsEnterotoxinsFamilial Mediterranean FeverHEK293 CellsHumansInflammasomesLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutMicrotubulesPyrinBacterial ToxinsCARD Signaling Adaptor ProteinsEnterotoxinsInflammasomesLipopolysaccharidesMEFV protein, humanMefv protein, mousePYCARD protein, humanPyrintcdA protein, Clostridium difficileTubulincolchicineFMFinflammasomemicrotubulesPyrin

Identifiers

PMID27911804
PMCPMC5167202
OpenAlexW2555349454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.